-
Je něco špatně v tomto záznamu ?
Cadmium-Induced Hepatotoxicity in Mice - Prophylactic Supplementation of Quercetin Exerts Hepatoprotective Effect by Modulating PI3K/Akt/NF-kappaB Signaling Pathway
L. Liu, Q. Zhao, J. Huang, S. Lei
Status minimální Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
PubMed Central
od 2020
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- antioxidancia * farmakologie MeSH
- fosfatidylinositol-3-kinasy * metabolismus MeSH
- játra účinky léků patologie metabolismus MeSH
- kadmium * toxicita MeSH
- lékové postižení jater * prevence a kontrola metabolismus patologie MeSH
- myši inbrední C57BL * MeSH
- myši MeSH
- NF-kappa B * metabolismus MeSH
- oxidační stres účinky léků MeSH
- protoonkogenní proteiny c-akt * metabolismus MeSH
- quercetin * farmakologie terapeutické užití MeSH
- signální transdukce * účinky léků MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
This current study seeks to examine the pre-protective function of Quercetin in Cadmium (Cd)-induced liver damage, along with its modulation of the PI3K/Akt/NF-kappaB signaling pathway. A total of 60 male C57BL/6J mice were randomly assigned to four groups: control (C), quercetin (Q, 100 mg/kg/day), Cd (Cd, 2.5 mg/kg/day), and quercetin and Cd (Q+Cd). Before receiving Cd treatment, quercetin was administered intragastrically for 4 weeks. In the present study, liver markers, oxidative stress parameters, pro-inflammatory cytokines, liver histopathology, apoptotic markers and PI3K/Akt/NF-kappaB signaling molecules were examined. We observed that the body weight of the Cd-treated mice dramatically rise after 4 weeks of quercetin pre-administration, and the Cd concentration was significantly decreased. Liver function markers like alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH) were significantly reduced in quercetin treatment in Cd-induced mice. Additionally, we observed that quercetin reduced Cd-mediated liver injury in mice by assessing the level of malondialdehyde (MDA), and the activities of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione (GSH) concentrations and the histological alterations. By monitoring tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1beta (IL-1beta), quercetin successfully reduced the inflammatory cytokines that the Cd metal caused in the liver. Additionally, in the liver tissues of Cd-mediated, quercetin could enhance the expression of Bcl-2 and decrease the expression of p-Akt, p-PI3K, Bax, Caspase-9, Caspase-3, NF-kappaB. In conclusion, quercetin protects against Cd induced liver injury via several pathways, including oxidative stress, inflammation and apoptosis, and its protective effect correlates with antioxidant activity.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24022810
- 003
- CZ-PrNML
- 005
- 20250502110008.0
- 007
- ta
- 008
- 241205s2024 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.935252 $2 doi
- 035 __
- $a (PubMed)39530906
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Liu, L $u Department of Pharmacy, Wuxi No. 2 People's Hospital, Wuxi, China; Xi'an International Medical Center Hospital, Xi'an, China. gracelee03@sina.com
- 245 10
- $a Cadmium-Induced Hepatotoxicity in Mice - Prophylactic Supplementation of Quercetin Exerts Hepatoprotective Effect by Modulating PI3K/Akt/NF-kappaB Signaling Pathway / $c L. Liu, Q. Zhao, J. Huang, S. Lei
- 520 9_
- $a This current study seeks to examine the pre-protective function of Quercetin in Cadmium (Cd)-induced liver damage, along with its modulation of the PI3K/Akt/NF-kappaB signaling pathway. A total of 60 male C57BL/6J mice were randomly assigned to four groups: control (C), quercetin (Q, 100 mg/kg/day), Cd (Cd, 2.5 mg/kg/day), and quercetin and Cd (Q+Cd). Before receiving Cd treatment, quercetin was administered intragastrically for 4 weeks. In the present study, liver markers, oxidative stress parameters, pro-inflammatory cytokines, liver histopathology, apoptotic markers and PI3K/Akt/NF-kappaB signaling molecules were examined. We observed that the body weight of the Cd-treated mice dramatically rise after 4 weeks of quercetin pre-administration, and the Cd concentration was significantly decreased. Liver function markers like alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH) were significantly reduced in quercetin treatment in Cd-induced mice. Additionally, we observed that quercetin reduced Cd-mediated liver injury in mice by assessing the level of malondialdehyde (MDA), and the activities of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione (GSH) concentrations and the histological alterations. By monitoring tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1beta (IL-1beta), quercetin successfully reduced the inflammatory cytokines that the Cd metal caused in the liver. Additionally, in the liver tissues of Cd-mediated, quercetin could enhance the expression of Bcl-2 and decrease the expression of p-Akt, p-PI3K, Bax, Caspase-9, Caspase-3, NF-kappaB. In conclusion, quercetin protects against Cd induced liver injury via several pathways, including oxidative stress, inflammation and apoptosis, and its protective effect correlates with antioxidant activity.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a quercetin $x farmakologie $x terapeutické užití $7 D011794
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a NF-kappa B $x metabolismus $7 D016328
- 650 12
- $a protoonkogenní proteiny c-akt $x metabolismus $7 D051057
- 650 _2
- $a myši $7 D051379
- 650 12
- $a signální transdukce $x účinky léků $7 D015398
- 650 12
- $a kadmium $x toxicita $7 D002104
- 650 12
- $a myši inbrední C57BL $7 D008810
- 650 12
- $a fosfatidylinositol-3-kinasy $x metabolismus $7 D019869
- 650 12
- $a lékové postižení jater $x prevence a kontrola $x metabolismus $x patologie $7 D056486
- 650 12
- $a antioxidancia $x farmakologie $7 D000975
- 650 _2
- $a oxidační stres $x účinky léků $7 D018384
- 650 _2
- $a játra $x účinky léků $x patologie $x metabolismus $7 D008099
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Zhao, Q
- 700 1_
- $a Huang, J
- 700 1_
- $a Lei, S
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 73, č. 5 (2024), s. 703-716
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39530906 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y - $z 0
- 990 __
- $a 20241205 $b ABA008
- 991 __
- $a 20250502110000 $b ABA008
- 999 __
- $a min $b bmc $g 2283539 $s 1234815
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 73 $c 5 $d 703-716 $e 20241112 $i 1802-9973 $m Physiological research $n Physiol Res $x MED00003824
- LZP __
- $a Pubmed-20241205
